Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

IRELAND: Survey Shows Most Addicts Use Multiple Drugs




 

Irish Times (05.28.2013)

Merchants Quay Ireland and Ana Liffey Drug Project, nonprofit organizations that provide services to people with addiction issues, reported that most addicts now used several different drugs, which meant that single-drug detoxification programs did not match addicts’ needs. A survey of 388 needle program clients indicated two-thirds used multiple drugs during the past month: 30 percent used two drugs; 25 percent used three drugs; 12 percent used four drugs; and 2 percent used five drugs. The drugs used most often included heroin (86 percent), prescribed methadone (49 percent), benzodiazepines (34 percent), cannabis (24 percent), alcohol (22 percent), and cocaine (6 percent). The report recommended “supervised injecting” centers similar to models in Sydney and Madrid to lower the risk of HIV and hepatitis C. The survey indicated that 45 percent of Ana Liffey Drug Project and Merchants Quay clients had hepatitis C. Twenty-seven percent of survey respondents stated they shared syringes, which increased the risk of hepatitis C and HIV transmission. Merchants Quay Ireland Chief Executive Officer Tony Geoghegan recommended developing polydrug detoxification regimens and increasing testing for hepatitis C and “other blood-borne” viruses to reduce the spread of the viruses and improve the health of the clients.



 


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in May 28, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.